Implementation of precision medicine requires a multidisciplinary and systematic approach
In his State of the Union address on 20 January 2015, United States President Barack Obama announced a new initiative in precision medicine, which aims to give “access to the personalised information we need to keep ourselves and our families healthier”.1 So, what is precision medicine? Previously referred to as personalised medicine, it can be defined as the correlation of innate and external factors at an individual level, to better understand the pattern of disease and its impact on the individual, and thus to tailor prevention, intervention and treatment. Precision medicine thus combines genomic and epigenomic data with environmental exposure and lifestyle factors. It has the potential not only to improve health outcomes but to save money by better targeting health interventions to those individuals most likely to benefit.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
I am indebted to Terence O’Brien and Melissa Southey who reviewed the manuscript.
I am a member of the National Health and Medical Research Council Human Genetics Advisory Committee.